APO RESEARCH · REPORT
Medical Cold Plasma
Cold plasma is generated by applying energy to a gas, which makes the gas molecules or atoms lose their outer electrons and become ionized. It is comprised of a reactive mix of electrons, ions, excited atoms, and molecules – reactive species (e.g. O3, NO, NO2, etc.), UV radiation, and heat. Cold plasma is maintained at temperatures below 40°C, which unlike hot plasma enables it to be applied to living organisms.
Product & engineering
Understand the product.
Cold plasma is generated by applying energy to a gas, which makes the gas molecules or atoms lose their outer electrons and become ionized. It is comprised of a reactive mix of electrons, ions, excited atoms, and molecules – reactive species (e.g. O3, NO, NO2, etc.), UV radiation, and heat. Cold plasma is maintained at temperatures below 40°C, which unlike hot plasma enables it to be applied to living organisms.
Cold plasma in medicine has been shown to inactivate or reduce bacteria, fungi, viruses, spores and allergens, odor, and harmful molecules very efficiently. Extensive research has shown that the concentration and composition of cold plasma components can vary significantly for different plasma sources. It is this ability to modify the cold plasma for specific purposes that makes it possible to design a unique cold plasma technology for many different medical applications. Multiple studies show its use in the field of dentistry, implantology, dermatology, oncology, and as a treatment for antibiotic-resistant strains of bacteria.
Selected research
Industry Research
Medical Cold Plasma Industry Research Report 2026
Market perspective
Cold plasma is generated by applying energy to a gas, which makes the gas molecules or atoms lose their outer electrons and become ionized. It is comprised of a reactive mix of electrons, ions, excited atoms, and molecules – reactive species (e.g. O3, NO, NO2, etc.), UV radiation, and heat. Cold plasma is maintained at temperatures below 40°C, which unlike hot plasma enables it to be applied to living organisms.
Cold plasma in medicine has been shown to inactivate or reduce bacteria, fungi, viruses, spores and allergens, odor, and harmful molecules very efficiently. Extensive research has shown that the concentration and composition of cold plasma components can vary significantly for different plasma sources. It is this ability to modify the cold plasma for specific purposes that makes it possible to design a unique cold plasma technology for many different medical applications. Multiple studies show its use in the field of dentistry, implantology, dermatology, oncology, and as a treatment for antibiotic-resistant strains of bacteria.
The global Medical Cold Plasma market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
Read the full market overview
The North America market for Medical Cold Plasma is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Medical Cold Plasma is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
The Asia Pacific market for Medical Cold Plasma is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Medical Cold Plasma include Apyx Medical, Terraplasma Medical, Wacker Chemie, Neoplas Tools, ADTEC Plasma Technology, Plasmatreat GmbH, Relyon Plasma GmbH, Cinogy GmbH and Plasma Bioscience, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Medical Cold Plasma market in terms of revenue (US$ million) and, where applicable, sales volume (Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Medical Cold Plasma Market by Company
Apyx Medical
Terraplasma Medical
Wacker Chemie
Neoplas Tools
ADTEC Plasma Technology
Plasmatreat GmbH
Relyon Plasma GmbH
Cinogy GmbH
Plasma Bioscience
PlasmaMed
Nova Plasma
Medical Cold Plasma Segment by Type
Microwave Plasma
Radio Frequency Plasma
Direct Current Plasma
Medical Cold Plasma Segment by Application
Sterilization and Disinfection
Coagulation and Hemostasis
Dental Applications
Wound Healing
Dermatology Treatment
Beauty and Skin Care
Tumor Treatment
Transfection and Drug Delivery
Material Surface Modification
Medical Cold Plasma Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Cold Plasma market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medical Cold Plasma and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Cold Plasma.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Medical Cold Plasma manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Medical Cold Plasma by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Medical Cold Plasma in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Microwave Plasma
- Radio Frequency Plasma
- Direct Current Plasma
Applications
- Sterilization and Disinfection
- Coagulation and Hemostasis
- Dental Applications
- Wound Healing
- Dermatology Treatment
- Beauty and Skin Care
- Tumor Treatment
- Transfection and Drug Delivery
- Material Surface Modification
Companies covered
- Apyx Medical
- Terraplasma Medical
- Wacker Chemie
- Neoplas Tools
- ADTEC Plasma Technology
- Plasmatreat GmbH
- Relyon Plasma GmbH
- Cinogy GmbH
- Plasma Bioscience
- PlasmaMed
- Nova Plasma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Medical Cold Plasma Market Size (2021-2032)
- 2.2.2 Global Medical Cold Plasma Sales (2021-2032)
- 2.2.3 Global Medical Cold Plasma Market Average Price (2021-2032)
- 2.3 Medical Cold Plasma by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Microwave Plasma
- 2.3.3 Radio Frequency Plasma
- 2.3.4 Direct Current Plasma
- 2.4 Medical Cold Plasma by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Sterilization and Disinfection
- 2.4.3 Coagulation and Hemostasis
- 2.4.4 Dental Applications
- 2.4.5 Wound Healing
- 2.4.6 Dermatology Treatment
- 2.4.7 Beauty and Skin Care
- 2.4.8 Tumor Treatment
- 2.4.9 Transfection and Drug Delivery
- 2.4.10 Material Surface Modification
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Medical Cold Plasma Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Medical Cold Plasma Sales (Units) of Manufacturers (2021-2026)
- 3.3 Global Medical Cold Plasma Revenue of Manufacturers (2021-2026)
- 3.4 Global Medical Cold Plasma Average Price by Manufacturers (2021-2026)
- 3.5 Global Medical Cold Plasma Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Medical Cold Plasma, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Medical Cold Plasma, Product Type & Application
- 3.8 Global Manufacturers of Medical Cold Plasma, Established Date
- 3.9 Global Medical Cold Plasma Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Apyx Medical
- 4.1.1 Apyx Medical Company Information
- 4.1.2 Apyx Medical Business Overview
- 4.1.3 Apyx Medical Medical Cold Plasma Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Apyx Medical Medical Cold Plasma Product Portfolio
- 4.1.5 Apyx Medical Recent Developments
- 4.2 Terraplasma Medical
- 4.2.1 Terraplasma Medical Company Information
- 4.2.2 Terraplasma Medical Business Overview
- 4.2.3 Terraplasma Medical Medical Cold Plasma Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Terraplasma Medical Medical Cold Plasma Product Portfolio
- 4.2.5 Terraplasma Medical Recent Developments
- 4.3 Wacker Chemie
- 4.3.1 Wacker Chemie Company Information
- 4.3.2 Wacker Chemie Business Overview
- 4.3.3 Wacker Chemie Medical Cold Plasma Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Wacker Chemie Medical Cold Plasma Product Portfolio
- 4.3.5 Wacker Chemie Recent Developments
- 4.4 Neoplas Tools
- 4.4.1 Neoplas Tools Company Information
- 4.4.2 Neoplas Tools Business Overview
- 4.4.3 Neoplas Tools Medical Cold Plasma Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Neoplas Tools Medical Cold Plasma Product Portfolio
- 4.4.5 Neoplas Tools Recent Developments
- 4.5 ADTEC Plasma Technology
- 4.5.1 ADTEC Plasma Technology Company Information
- 4.5.2 ADTEC Plasma Technology Business Overview
- 4.5.3 ADTEC Plasma Technology Medical Cold Plasma Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 ADTEC Plasma Technology Medical Cold Plasma Product Portfolio
- 4.5.5 ADTEC Plasma Technology Recent Developments
- 4.6 Plasmatreat GmbH
- 4.6.1 Plasmatreat GmbH Company Information
- 4.6.2 Plasmatreat GmbH Business Overview
- 4.6.3 Plasmatreat GmbH Medical Cold Plasma Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Plasmatreat GmbH Medical Cold Plasma Product Portfolio
- 4.6.5 Plasmatreat GmbH Recent Developments
- 4.7 Relyon Plasma GmbH
- 4.7.1 Relyon Plasma GmbH Company Information
- 4.7.2 Relyon Plasma GmbH Business Overview
- 4.7.3 Relyon Plasma GmbH Medical Cold Plasma Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Relyon Plasma GmbH Medical Cold Plasma Product Portfolio
- 4.7.5 Relyon Plasma GmbH Recent Developments
- 4.8 Cinogy GmbH
- 4.8.1 Cinogy GmbH Company Information
- 4.8.2 Cinogy GmbH Business Overview
- 4.8.3 Cinogy GmbH Medical Cold Plasma Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Cinogy GmbH Medical Cold Plasma Product Portfolio
- 4.8.5 Cinogy GmbH Recent Developments
- 4.9 Plasma Bioscience
- 4.9.1 Plasma Bioscience Company Information
- 4.9.2 Plasma Bioscience Business Overview
- 4.9.3 Plasma Bioscience Medical Cold Plasma Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Plasma Bioscience Medical Cold Plasma Product Portfolio
- 4.9.5 Plasma Bioscience Recent Developments
- 4.10 PlasmaMed
- 4.10.1 PlasmaMed Company Information
- 4.10.2 PlasmaMed Business Overview
- 4.10.3 PlasmaMed Medical Cold Plasma Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 PlasmaMed Medical Cold Plasma Product Portfolio
- 4.10.5 PlasmaMed Recent Developments
- 4.11 Nova Plasma
- 4.11.1 Nova Plasma Company Information
- 4.11.2 Nova Plasma Business Overview
- 4.11.3 Nova Plasma Medical Cold Plasma Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Nova Plasma Medical Cold Plasma Product Portfolio
- 4.11.5 Nova Plasma Recent Developments
5 Global Medical Cold Plasma Market Scenario by Region
- 5.1 Global Medical Cold Plasma Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Medical Cold Plasma Sales by Region: 2021-2032
- 5.2.1 Global Medical Cold Plasma Sales by Region: 2021-2026
- 5.2.2 Global Medical Cold Plasma Sales by Region: 2027-2032
- 5.3 Global Medical Cold Plasma Revenue by Region: 2021-2032
- 5.3.1 Global Medical Cold Plasma Revenue by Region: 2021-2026
- 5.3.2 Global Medical Cold Plasma Revenue by Region: 2027-2032
- 5.4 North America Medical Cold Plasma Market Facts & Figures by Country
- 5.4.1 North America Medical Cold Plasma Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Medical Cold Plasma Sales by Country (2021-2032)
- 5.4.3 North America Medical Cold Plasma Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Medical Cold Plasma Market Facts & Figures by Country
- 5.5.1 Europe Medical Cold Plasma Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Medical Cold Plasma Sales by Country (2021-2032)
- 5.5.3 Europe Medical Cold Plasma Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Medical Cold Plasma Market Facts & Figures by Country
- 5.6.1 Asia Pacific Medical Cold Plasma Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Medical Cold Plasma Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Medical Cold Plasma Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Medical Cold Plasma Market Facts & Figures by Country
- 5.7.1 South America Medical Cold Plasma Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Medical Cold Plasma Sales by Country (2021-2032)
- 5.7.3 South America Medical Cold Plasma Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Medical Cold Plasma Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Medical Cold Plasma Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Medical Cold Plasma Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Medical Cold Plasma Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Medical Cold Plasma Sales by Type (2021-2032)
- 6.1.1 Global Medical Cold Plasma Sales by Type (2021-2032) & (Units)
- 6.1.2 Global Medical Cold Plasma Sales Market Share by Type (2021-2032)
- 6.2 Global Medical Cold Plasma Revenue by Type (2021-2032)
- 6.2.1 Global Medical Cold Plasma Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Medical Cold Plasma Revenue Market Share by Type (2021-2032)
- 6.3 Global Medical Cold Plasma Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Medical Cold Plasma Sales by Application (2021-2032)
- 7.1.1 Global Medical Cold Plasma Sales by Application (2021-2032) & (Units)
- 7.1.2 Global Medical Cold Plasma Sales Market Share by Application (2021-2032)
- 7.2 Global Medical Cold Plasma Revenue by Application (2021-2032)
- 7.2.1 Global Medical Cold Plasma Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Medical Cold Plasma Revenue Market Share by Application (2021-2032)
- 7.3 Global Medical Cold Plasma Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Medical Cold Plasma Value Chain Analysis
- 8.1.1 Medical Cold Plasma Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Medical Cold Plasma Production Mode & Process
- 8.2 Medical Cold Plasma Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Medical Cold Plasma Distributors
- 8.2.3 Medical Cold Plasma Customers
9 Global Medical Cold Plasma Analyzing Market Dynamics
- 9.1 Medical Cold Plasma Industry Trends
- 9.2 Medical Cold Plasma Industry Drivers
- 9.3 Medical Cold Plasma Industry Opportunities and Challenges
- 9.4 Medical Cold Plasma Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst